The ALDH2 gene: what it is, how it causes Asian flush, and what to do about it

540 million people worldwide carry a defective copy of the ALDH2 gene — the result of a single amino acid mutation where glutamate swaps to lysine at position 487. One nucleotide change. One enzyme crippled. Half a billion people affected. It's the most common enzyme deficiency in humans, and it's the reason an estimated 36% of East Asians turn red, feel nauseous, or get a pounding heartbeat after even a small amount of alcohol.

That mutation, known as ALDH2*2, doesn't just cause Asian flush. It disables the enzyme responsible for clearing acetaldehyde — a toxic, carcinogenic byproduct of alcohol metabolism — leaving carriers exposed every time they drink. The health consequences go far beyond a red face.

This article breaks down what the ALDH2 gene does, how ALDH2 deficiency disrupts alcohol metabolism at the molecular level, who carries the variant, what diseases it's linked to, and what options exist for managing it.

What is the ALDH2 gene?

The ALDH2 gene sits on chromosome 12 (specifically at position 12q24.12) and provides the instructions for building an enzyme called aldehyde dehydrogenase 2. That enzyme lives inside your mitochondria, the energy-producing compartments of your cells, and has one primary job: converting a toxic molecule called acetaldehyde into harmless acetic acid (essentially vinegar).

Why does this matter? Because acetaldehyde is what your body produces every time you drink alcohol. It's the intermediate compound in alcohol metabolism, and it's extremely toxic. Your ALDH2 enzyme is the cleanup crew responsible for getting rid of it.

When the ALDH2 gene is working normally, your body clears acetaldehyde quickly and efficiently. You drink, you process, you move on. But when the gene carries a specific mutation, and roughly 540 million people worldwide have it, that cleanup crew shows up understaffed and underpowered. Acetaldehyde sticks around, and your body lets you know about it in some very unpleasant ways.

The two-step pathway: how your body (should) break down alcohol

To understand why the ALDH2 gene matters so much, you need to see the full picture of how your body handles alcohol. It's a two-step process, and both steps need to work for things to go smoothly.

Step 1: Ethanol to acetaldehyde. When you take a drink, an enzyme called alcohol dehydrogenase (ADH1B) gets to work in your liver, converting ethanol into acetaldehyde. This reaction uses a cofactor called NAD+, which gets reduced to NADH in the process. In some people, particularly those with the ADH1B*2 variant common in East Asian populations, this step actually happens faster than normal, flooding the system with acetaldehyde at an accelerated rate.

Step 2: Acetaldehyde to acetic acid. This is where ALDH2 comes in. The aldehyde dehydrogenase 2 enzyme, sitting inside your mitochondria, takes that toxic acetaldehyde and converts it into acetic acid, a harmless compound your body can break down further into CO2 and water. This step also requires NAD+ as a cofactor.

When both steps work properly, the whole process is seamless. Acetaldehyde exists in your body for only a brief moment before being neutralized.

But here's the problem: when your ALDH2 enzyme is impaired, step 2 can't keep pace with step 1. Acetaldehyde accumulates in your blood, tissues, and organs. And acetaldehyde isn't just "a bit unpleasant." The International Agency for Research on Cancer (IARC) classifies it as a Group 1 carcinogen, the same category as tobacco smoke and asbestos. It generates reactive oxygen species (ROS), damages DNA, and triggers the cascade of symptoms that anyone with ALDH2 deficiency knows all too well: flushing, rapid heartbeat, nausea, headaches.

For a deeper look at this process, see our guide on how your body breaks down acetaldehyde.

The ALDH2*2 mutation: what changes at the genetic level

So what exactly goes wrong in the gene? This is where the science gets specific.

The mutation responsible for ALDH2 deficiency is a single nucleotide change known as rs671. It's a G-to-A substitution on exon 12 of the ALDH2 gene. At the protein level, this swaps out a glutamate amino acid for a lysine at position 487, a change written in shorthand as Glu487Lys (you'll sometimes see older literature referring to it as position 504, based on a different numbering convention).

That single amino acid swap has outsized consequences because of how the ALDH2 enzyme is built. The functional enzyme is a tetramer, made up of four protein subunits that lock together to form the working molecule. When even one of those four subunits carries the Lys487 variant (the ALDH2*2 allele), it disrupts the structural integrity of the entire complex. This is what scientists call a dominant-negative effect: the defective subunit doesn't just fail to contribute, it actively sabotages the other subunits.

This is why the inheritance pattern is so striking:

• ALDH2*1/*1 (wild-type): All four subunits are normal. Full enzyme activity. No flush.
• ALDH2*1/*2 (heterozygous): You carry one normal copy and one mutant copy. But because the defective subunits poison the tetramers they join, your overall ALDH2 activity drops to roughly 17–25% of normal. That's not half — it's a quarter or less.
• ALDH2*2/*2 (homozygous): Both copies carry the mutation. Virtually every tetramer is compromised. Residual enzyme activity is around 1–5% of normal, effectively nonfunctional.

This explains something that confuses a lot of people: if you only need one bad copy to lose 75%+ of your enzyme activity, the mutation behaves almost like a dominant trait in practice. One copy is enough to cause symptoms. Two copies makes them severe.

According to Chen et al. (2022), this variant is the most common enzyme deficiency in the world, affecting an estimated 8% of the global population, concentrated heavily in East Asian communities.

Who carries ALDH2*2? Prevalence and population genetics

The ALDH2*2 variant is overwhelmingly concentrated in East Asian populations. Studies estimate that 30–40% of people of Han Chinese, Japanese, Korean, and Vietnamese descent carry at least one copy. That translates to roughly 540 million carriers worldwide, making ALDH2 deficiency one of the most common genetic enzyme deficiencies on the planet.

The distribution isn't random. It traces back to a founder effect, a single mutation event that occurred thousands of years ago in central China and spread through migration patterns across East and Southeast Asia. The allele frequency is highest in southeastern China, Japan, and Korea, and tapers off as you move west and south.

Can non-Asian people carry the ALDH2*2 variant? Yes, but it's rare. Small frequencies have been documented in some Middle Eastern populations, and isolated cases appear in people of European descent. If you're not of East Asian heritage and you experience alcohol flush symptoms, it's still worth checking, but statistically, other causes (like histamine intolerance or ingredient sensitivities) are more likely.

Many East Asian carriers also carry the ADH1B*2 variant, which speeds up the first step of alcohol metabolism. If you have both, a fast ADH1B and a slow ALDH2, you're producing acetaldehyde faster than normal and clearing it slower than normal. That double hit intensifies symptoms considerably.

Heterozygous vs. homozygous: why the same gene causes different symptoms

One of the most common questions people have after learning about ALDH2 is: "I have the gene, but my friend has it too and their reaction is way worse (or way milder) than mine. Why?"

The answer almost always comes down to whether you're heterozygous or homozygous for the ALDH2*2 variant.

Heterozygous carriers (ALDH2*1/*2) make up the majority of affected individuals. With roughly 17–25% residual enzyme activity, their symptoms are typically mild to moderate:

• Facial flushing after one or two drinks (sometimes just the cheeks, sometimes the full face, neck, and chest)
• Elevated heart rate (tachycardia)
• Nasal congestion or a runny nose
• Mild nausea or headache

Many heterozygous carriers can tolerate small amounts of alcohol, especially if they drink slowly, stay hydrated, and choose lower-congener drinks. Some develop an apparent "tolerance" over time, but this is misleading. The flushing may become less visible as the body adapts its surface-level response, but the acetaldehyde exposure underneath hasn't changed. The health risks remain.

Homozygous carriers (ALDH2*2/*2) are a different story. With virtually no functional ALDH2 enzyme, even tiny amounts of alcohol can trigger:

• Severe nausea and vomiting
• Intense, full-body flushing
• Dangerous drops in blood pressure (hypotension)
• Rapid onset of symptoms, sometimes within minutes

Most homozygous carriers avoid alcohol entirely, not by choice, but because the experience is genuinely intolerable. If you know someone who "physically cannot drink," they may well be ALDH2*2/*2.

Symptom severity can also be modified by whether you carry the ADH1B*2 fast-metabolizer variant. If you do, acetaldehyde floods in faster, making symptoms worse regardless of your ALDH2 status. This is why two heterozygous carriers can have noticeably different experiences: their ADH1B background matters too.

For more on what's happening when you flush, see our breakdown of why your face turns red when you drink.

If you're an ALDH2*1/*2 carrier (the most common type), Sunset is formulated to support acetaldehyde clearance so you can drink more comfortably. Learn how Sunset works ->

What diseases are linked to the ALDH2 gene?

ALDH2 deficiency isn't just about uncomfortable drinking experiences. The accumulated acetaldehyde exposure carries real, documented health consequences, and every carrier should understand them.

Esophageal cancer. The strongest and most alarming association. Brooks et al. (2009) published a landmark review in PLOS Medicine showing that ALDH2*2 carriers who drink regularly face up to a 12-fold increased risk of esophageal squamous cell carcinoma (ESCC) compared to non-carriers. The mechanism is direct: acetaldehyde forms DNA adducts (specifically N2-ethyl-deoxyguanosine) that damage the cells lining the esophagus. Over years of repeated exposure, this damage can become cancerous.

This risk is dose-dependent. Carriers who drink heavily are at the highest risk, but even moderate drinking elevates it compared to carriers who abstain. For a detailed look at the evidence, read our piece on ALDH2 deficiency and cancer risk.

Other cancers. Beyond the esophagus, ALDH2 deficiency has been linked to elevated rates of head and neck cancers, stomach cancer, and hepatocellular carcinoma (liver cancer) in carriers who drink. The common thread is always acetaldehyde exposure.

Fanconi anemia connection. Researchers have discovered that the ALDH2 enzyme plays a role in the Fanconi anemia DNA repair pathway. When ALDH2 is impaired, the body has reduced capacity to repair the specific type of DNA damage caused by aldehydes, including those produced by normal cellular metabolism, not just alcohol. This has implications for blood cell production and bone marrow health.

Cardiovascular effects. The relationship between ALDH2 and heart disease is complex. Some research suggests ALDH2 plays a protective role in cardiac tissue by clearing toxic aldehydes generated during oxidative stress (like during a heart attack). ALDH2*2 carriers may therefore lose some of this cardioprotective function. However, because carriers tend to drink less, the net cardiovascular effect in population studies is hard to untangle.

Knowing your ALDH2 status is genuinely useful health information. If you carry the variant and choose to drink, that knowledge shapes how you manage your risk.

How to test for the ALDH2 gene variant

If you're wondering whether you carry the ALDH2*2 variant, you have several options ranging from free and informal to lab-verified.

Consumer genomics (23andMe, AncestryDNA). The easiest route for most people. 23andMe includes an Alcohol Flush Reaction report in their health package. If you've already been tested, you can also download your raw genotype data and search for rs671 directly. Here's what the results mean:

• GG = ALDH2*1/*1 (wild-type, no deficiency)
• GA = ALDH2*1/*2 (heterozygous carrier, reduced enzyme activity)
• AA = ALDH2*2/*2 (homozygous carrier, severely reduced enzyme activity)

Third-party analysis tools like Promethease or GeneCards can parse your raw data from any major testing service and give you a detailed breakdown of your ALDH2 genotype alongside hundreds of other variants.

Clinical genetic testing is available but usually unnecessary for this specific variant. Most doctors won't order it unless you're being evaluated for a broader genetic condition. The consumer tests are accurate and far cheaper.

The at-home flush test. No DNA kit? You can get a reasonable (though not definitive) answer empirically. Drink a small amount of alcohol (half a standard drink) on an empty stomach and observe. If your face, neck, or chest flush red within 15–30 minutes, you very likely carry at least one copy of ALDH2*2. It's not lab-grade evidence, but it's been the screening method used in clinical settings in Japan for decades.

Just found out you have ALDH2*2? You're not alone — around 540 million people worldwide carry this variant. Here's what that means for you and what you can do about it.

Managing ALDH2 deficiency: what can you actually do?

Here's the honest truth: ALDH2 deficiency is permanent. You can't up-regulate a structurally defective enzyme, and no amount of "training" or exposure will fix the underlying genetics. But that doesn't mean you're helpless.

Support acetaldehyde clearance. Your body has backup pathways for dealing with acetaldehyde, and they can be supported with the right nutrients. Sunset Alcohol Flush Support is formulated around this principle, using ingredients like NAC (N-acetyl cysteine), dihydromyricetin (DHM), B vitamins, and other acetaldehyde-targeting compounds to help your body process what the impaired ALDH2 enzyme can't handle alone. It supports the metabolic bottleneck where the problem actually occurs.

Drink strategically. Choose lower-congener drinks (clear spirits like vodka or gin produce fewer additional aldehydes than dark spirits, red wine, or beer). Pace yourself. Eat before and while drinking. Stay hydrated. These aren't revolutionary tips, but they meaningfully reduce the acetaldehyde load your body has to process.

Know your limits, and respect them. This applies especially to homozygous carriers, for whom even small amounts of alcohol can cause serious symptoms. There's no shame in choosing not to drink. For heterozygous carriers, understanding that your "tolerance" for flushing doesn't mean tolerance for acetaldehyde exposure is an important distinction.

Stay informed about long-term risks. If you carry ALDH2*2 and choose to drink, regular check-ups matter. Discuss your carrier status with your doctor, particularly regarding esophageal screening if you drink regularly.

The ALDH2 gene is one of those rare cases where a single genetic variant has a clear, measurable, and actionable impact on your daily life. Understanding it doesn't change your DNA, but it changes how you make decisions.

Ready to support your body's acetaldehyde clearance? Sunset is specifically designed for people with ALDH2 deficiency. Try Sunset ->